Thursday 20 June 2013 Register Login

You are here:

Home

New neurology product

Complete an online survey about new products for stroke prevention and receive €225. Click here

LATEST ISSUE

Medication safety, improving patient outcomes, ‘smart’ pump implementation, monitoring of cleanrooms, aclidium bromide in the treatment of COPD, managing pain in renal impairment, labelling, cardiovascular disease risk management, RTU/RTA injections, preventing ischaemic stroke, topical anaesthetics in dermatology, High 5s

View Issue

Hospital Pharmacy Europe Issue 62 May/June 2012

oral anticoagulants, drug shortages, cytotoxics, Xaluprine, chronic kidney disease, IV catheter technology, oral chemotherapy, hospital-acquired pneumonia, biosimilar cost-effective-ness, oral chemotherapy

Choose another issue:

Articles

LEADER

Vorsprung durch Technik
Tuesday 24th July 2012
The recent German hospital pharmacists’ congress in Mainz raised some interesting and important...

CONFERENCE MEETING REPORTS

Special patient groups – hospital pharmacists creating...
Tuesday 24th July 2012
More than 3500 participants from six continents attended the 17th Congress of the European...

CONFERENCE MEETING REPORTS

New oral anticoagulants: evidence and decisions
Tuesday 24th July 2012
Experts at a satellite symposium sponsored by Bayer described the evidence for effectiveness of the...

CONFERENCE MEETING REPORTS

A collaborative approach to reducing drug shortages
Tuesday 24th July 2012
Addressing drug shortages and safeguarding patient care were the focus of an Amgen-sponsored media...

CONFERENCE MEETING REPORTS

Recognising the dangers that cytotoxics can present
Tuesday 24th July 2012
Some worrying observations were highlighted during a satellite seminar sponsored by Fresenius Kabi,...

CONFERENCE MEETING REPORTS

Is patient safety affordable?
Tuesday 24th July 2012
Experts speaking at a satellite symposium sponsored by B Braun described how standardised...

OPINION

What's in my medicine and is it safe?
Tuesday 24th July 2012
OPINION

DRUG EVALUATION

Xaluprine in acute lymphoblastic leukaemia
Tuesday 24th July 2012
Although mercaptopurine has been used for the slowing down of progression of acute lymphoblastic...

PHARMACEUTICAL THERAPEUTICS

Chronic kidney disease: A pathway to administer intravenous...
Wednesday 25th July 2012
The chronic kidney disease population has a high incidence of iron-deficiency anaemia. This article...

PRACTICAL THERAPEUTICS

IV catheter technology: Benefits of closed IV catheter...
Wednesday 25th July 2012
Advances in intravenous catheter technology and the development of closed systems, such as BD...

PRACTICAL THERAPEUTICS

Acute myeloid leukaemia: Ceplene® as maintenance therapy in...
Wednesday 25th July 2012
The combination of interleukin-2 and histamine dihydrochloride (Ceplene®) is a safe and effective...

PRACTICAL THERAPEUTICS

Oral chemotherapy: developments in oral chemotherapy
Wednesday 25th July 2012
Oral cytotoxic drugs require the greatest need for careful consultation with the patient. The...

PRACTICAL THERAPEUTICS

Nosocomial pneumonia: a bird's eye view
Wednesday 25th July 2012
Nosocomial pneumonia is the second most common nosocomial infection and is usually bacterial in...

PRACTICAL THERAPEUTICS

Benefits and cost-effectiveness of Nivestim™ for febrile...
Wednesday 25th July 2012
Biosimilar medicines have emerged as potentially cost-effective alternatives to originator...

PRACTICAL THERAPEUTICS

Thromboprophylaxis during treatment with lenalidomide
Wednesday 25th July 2012
Multiple myeloma patients treated with lenalidomide are at risk of developing thrombotic events. To...

PRACTICAL THERAPEUTICS

Cost effectiveness of TNF-alpha inhibitors in RA
Wednesday 25th July 2012
A number of biologic drugs for the treatment of rheumatoid arthritis are now available, and real...

PHARMACOECONOMICS

Market access of orphan drugs: one size fits all?
Tuesday 24th July 2012
The European Union has introduced measures to stimulate the development of orphan drugs, and many...

VANTAGE POINT

Internet ban to stay
Tuesday 24th July 2012
Medicine is becoming one of the most highly regulated industries in the EU economy. This regulation...

Web design, hosting and programming by ModeZero